1. Slots J, Rams TE. New views on periodontal microbiota in special patient categories. J Clin Periodontol. 1991. 18:411–420.
2. Socransky SS, Haffajee AD. The bacterial etiology of destructive periodontal disease: current concepts. J Periodontol. 1992. 63:4 Suppl. 322–331.
3. Quirynen M, Bollen CM, Vandekerckhove BN, Dekeyser C, Papaioannou W, Eyssen H. Full- vs. partial-mouth disinfection in the treatment of periodontal infections: short-term clinical and microbiological observations. J Dent Res. 1995. 74:1459–1467.
4. Becker W, Becker BE, Berg LE. Periodontal treatment without maintenance. A retrospective study in 44 patients. J Periodontol. 1984. 55:505–509.
5. Lindhe J, Westfelt E, Nyman S, Socransky SS, Haffajee AD. Long-term effect of surgical/non-surgical treatment of periodontal disease. J Clin Periodontol. 1984. 11:448–458.
6. Escribano M, Herrera D, Morante S, Teughels W, Quirynen M, Sanz M. Efficacy of a low-concentration chlorhexidine mouth rinse in non-compliant periodontitis patients attending a supportive periodontal care programme: a randomized clinical trial. J Clin Periodontol. 2010. 37:266–275.
7. DePaola LG, Minah GE, Overholser CD, Meiller TF, Charles CH, Harper DS, et al. Effect of an antiseptic mouthrinse on salivary microbiota. Am J Dent. 1996. 9:93–95.
8. Herrera D, Santos S, Ferrus J, Barbieri G, Trombelli L, Sanz M. Efficacy of a 0.15% benzydamine hydrochloride and 0.05% cetylpyridinium chloride mouth rinse on 4-day de novo plaque formation. J Clin Periodontol. 2005. 32:595–603.
9. Quirynen M, Soers C, Desnyder M, Dekeyser C, Pauwels M, van Steenberghe D. A 0.05% cetyl pyridinium chloride/0.05% chlorhexidine mouth rinse during maintenance phase after initial periodontal therapy. J Clin Periodontol. 2005. 32:390–400.
10. Mandel ID. Chemotherapeutic agents for controlling plaque and gingivitis. J Clin Periodontol. 1988. 15:488–498.
11. Jorgensen MG, Slots J. Antimicrobials in periodontal maintenance. J Dent Hyg. 2001. 75:233–239.
12. Wu CD, Savitt ED. Evaluation of the safety and efficacy of over-the-counter oral hygiene products for the reduction and control of plaque and gingivitis. Periodontol 2000. 2002. 28:91–105.
13. Lang NP, Catalanotto FA, Knopfli RU, Antczak AA. Quality-specific taste impairment following the application of chlorhexidine digluconate mouthrinses. J Clin Periodontol. 1988. 15:43–48.
14. Pitten FA, Kramer A. Efficacy of cetylpyridinium chloride used as oropharyngeal antiseptic. Arzneimittelforschung. 2001. 51:588–595.
15. Silva MF, dos Santos NB, Stewart B, DeVizio W, Proskin HM. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis. J Clin Dent. 2009. 20:55–61.
16. Gaffar A, Afflitto J, Nabi N, Herles S, Kruger I, Olsen S. Recent advances in plaque, gingivitis, tartar and caries prevention technology. Int Dent J. 1994. 44:1 Suppl 1. 63–70.
17. Wu X, Zhang T, Zhang Y. Effect of a new triclosan-containing mouth rinse on oral infection. Zhonghua Kou Qiang Yi Xue Za Zhi. 2001. 36:301–303.
18. Zuckerbraun HL, Babich H, May R, Sinensky MC. Triclosan: cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur J Oral Sci. 1998. 106(2 Pt 1):628–636.
19. Masatake T, Hidekazu K, Yasuhiko A, Toshiyuki T, Akira S, Toshio H, et al. The clinical evaluation of mouth rinse for periodontal disease. Jpn J Conserv Dent. 2000. 43:703–711.
20. Fischman SL. Clinical index systems used to assess the efficacy of mouthrinses on plaque and gingivitis. J Clin Periodontol. 1988. 15:506–510.
21. Loe H, Silness J. Periodontal disease in pregnancy. I. Prevalence and severity. Acta Odontol Scand. 1963. 21:533–551.
22. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol. 1967. 38:Suppl. 610–616.
23. Axelsson P, Lindhe J. Efficacy of mouthrinses in inhibiting dental plaque and gingivitis in man. J Clin Periodontol. 1987. 14:205–212.
24. Engelberger T, Hefti A, Kallenberger A, Rateitschak KH. Correlations among Papilla Bleeding Index, other clinical indices and histologically determined inflammation of gingival papilla. J Clin Periodontol. 1983. 10:579–589.
25. Zimmer S, Kolbe C, Kaiser G, Krage T, Ommerborn M, Barthel C. Clinical efficacy of flossing versus use of antimicrobial rinses. J Periodontol. 2006. 77:1380–1385.
26. Mankodi S, Bauroth K, Witt JJ, Bsoul S, He T, Gibb R, et al. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque. Am J Dent. 2005. 18 Spec No:9A–14A.
27. Allen DR, Davies R, Bradshaw B, Ellwood R, Simone AJ, Robinson R, et al. Efficacy of a mouthrinse containing 0.05% cetylpyridinium chloride for the control of plaque and gingivitis: a 6-month clinical study in adults. Compend Contin Educ Dent. 1998. 19:2 Suppl. 20–26.
28. Nelson RF, Rodasti PC, Tichnor A, Lio YL. Comparative study of four over-the-counter mouthrinses claiming antiplaque and/or antigingivitis benefits. Clin Prev Dent. 1991. 13:30–33.
29. Charles CH, Mostler KM, Bartels LL, Mankodi SM. Comparative antiplaque and antigingivitis effectiveness of a chlorhexidine and an essential oil mouthrinse: 6-month clinical trial. J Clin Periodontol. 2004. 31:878–884.